ROVIELLO, GIANDOMENICO

ROVIELLO, GIANDOMENICO  

Dipartimento Universitario Clinico di Scienze mediche, chirurgiche e della salute  

Mostra records
Risultati 1 - 20 di 80 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autori File
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
A Phase II study of olaparib in breast cancer patients: Biological evaluation from a 'window of opportunity' trial 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Advances in systemic therapy for malignant mesothelioma: Future perspectives 1-gen-2017 Sobhani, NavidCorona, Silvia PaolaBonazza, DeborahIanza, AnnaRoviello, GiandomenicoCortale, MaurizioGuglielmi, AlessandraZanconati, FabrizioGenerali, Daniele +
Advances in systemic therapy for metastatic breast cancer: future perspectives 1-gen-2017 Corona, S. P.SOBHANI, NAVIDIANZA, ANNAROVIELLO, GIANDOMENICOMUSTACCHI, GIORGIOBORTUL, MARINAZANCONATI, FABRIZIOGENERALI, DANIELE
Apatinib for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib in metastatic gastric cancer: Can paclitaxel make the difference? 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer? 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer 1-gen-2018 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele +
Avelumab in gastric cancer 1-gen-2019 Roviello G.Generali D.De Manzini N.Sobhani N. +
Bevacizumab in small cell lung cancer 1-gen-2017 Roviello, GiandomenicoSobhani, NavidGenerali, Daniele
Cancer management during the COVID-19 world pandemic 1-gen-2023 Navid SobhaniGiandomenico RovielloBruna ScaggianteDaniele Generali +
Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer 1-gen-2017 Roviello, GiandomenicoCorona, Silvia PaolaGenerali, Daniele +
Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment 1-gen-2022 Generali D.Roviello G. +
Corticosteroid switch after progression on abiraterone acetate plus prednisone 1-gen-2020 Roviello G.Sobhani N.Corona S. +
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer? 1-gen-2017 Corona, Silvia PaolaRoviello, GiandomenicoGenerali, Daniele +
Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer 1-gen-2018 Sobhani, NavidGenerali, DanieleRoviello, Giandomenico +
Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer 1-gen-2018 Sobhani, NavidIanza, AnnaRoviello, GiandomenicoGiudici, FabiolaBortul, MarinaZanconati, FabrizioBottin, CristinaGenerali, Daniele +
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer 1-gen-2016 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +
Different efficacy of ramucirumab in patients with metastatic gastric and gastroesophageal junction cancer according to ECOG performance status 1-gen-2017 ROVIELLO, GIANDOMENICOGENERALI, DANIELE +